St Vincent’s BreastScreen Clinical Director, Adjunct Associate Professor Helen Frazer’s ground-breaking research has been recognised with two wins at the 2022 Women in AI Awards Australia and New Zealand.
Dr Frazer took out the top accolade of Innovator of the Year. She also won the Health Category, for world-first research she is leading that aims to improve the accuracy of breast cancer screening.
“I am deeply honoured by this recognition, which also acknowledges the incredible team and partners involved. Together, we are on a mission to transform breast cancer screening with AI,” said Dr Frazer.
According to Dr Frazer, the new AI-based models show promise to better detect cancer, lower unnecessary recalls to assessment, and improve timeliness, efficiency, and participation in treatment. Ultimately, it is hoped this can provide a more effective and personalised breast screening service to women.
The project, known as BRAIx, is being jointly developed by St Vincent’s Hospital Melbourne, St Vincent’s Institute of Medical Research, BreastScreen Victoria, The University of Melbourne, and the Australian Institute of Machine Learning at the University of Adelaide, in partnership with ACMD.
“The use of AI models may be a significant step in transforming screening, enabling more accurate detection when used in conjunction with a radiologist examining every mammogram,” says Dr Frazer who has worked in breast cancer screening for over 20 years.
Learn more about the BRAIx project at: https://www.acmd.org.au/braix
